US Markets

Horse racing-Justify failed drug test before Triple Crown win: NYT

Champion racehorse Justify failed a drug test shortly before winning the American Triple Crown in 2018, the New York Times reported on Wednesday.

Sept 11 (Reuters) - Champion racehorse Justify failed a drug test shortly before winning the American Triple Crown in 2018, the New York Times reported on Wednesday.

In an article posted on its website, the newspaper said Justify, who was under the stewardship of Hall of Fame trainer Bob Baffert, tested positive to the banned substance scopolamine after winning the Santa Anita Derby on April 7.

Scopolamine, also known as hyoscine, is banned in horse racing because it can improve horses' breathing and heart-rate.

The report said the failed drug test would normally have meant Justify's disqualification and forfeiture of entry into the Kentucky Derby.

Instead, the California Horse Racing Board took more than a month to confirm the results and moved to drop the case while lightening the penalty for any horse found to test positive to the same substance, the report said.

Justify won the Kentucky Derby, the first leg of the Triple Crown on May 5, before adding the Preakness Stakes and Belmont Stakes to become the 13th horse to complete the treble.

The Times quoted California Horse Racing Board executive Rick Baedeker as saying that it would have been "careless and reckless" for regulators to have rushed to complete an investigative report before the Kentucky Derby.

Baedeker did not immediately respond to a phone call and email request for comment by Reuters.

Efforts to contact Baffert were also unsuccessful.

(Reporting by Andrew Both in Cary, North Carolina; Editing by Ian Ransom)

((andrew.both@thomsonreuters.com; 1 919 6336697; Reuters Messaging: andrew.both.thomsonreuters.com@reuters.net))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Latest Markets Videos

    Reuters

    Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV.

    Learn More